Eric Batard

Eric Batard

Auto-generated profile, based on publicly available information

Eric Batard

Emergency Department

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2015 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
EMEmmanuel Montassier
Emmanuel Montassier
TGT. Gastinne
T. Gastinne
PVP. Vangay
P. Vangay
GAG. A. Al‐Ghalith
G. A. Al‐Ghalith
SVS. Bruley Des Varannes
S. Bruley Des Varannes
DKDan Knights
Dan Knights
Summary: Background: Chemotherapy is commonly used as myeloablative conditioning treatment to prepare patients for haematopoietic stem cell transplantation (HSCT). Chemotherapy leads to several side effects, with gastrointestinal (GI) mucositis being one of the most frequent. Current models of GI mucositis pathophysiology are generally silent on the role of the intestinal microbiome.Aim: To identify functional mechanisms by which the intestinal microbiome may play a key role in the pathophysiology of GI mucositis, we applied high‐throughput DNA‐sequencing analysis to identify microbes and microbial functions that are modulated following chemotherapy.Methods: We amplified and sequenced 16S rRNA genes from faecal samples before and after chemotherapy in 28 patients with non‐Hodgkin's lymphoma who received the same myeloablative conditioning regimen and no other concomitant therapy such as antibiotics.Results: We found that faecal samples collected after chemotherapy exhibited significant decreases in abundances of Firmicutes (P = 0.0002) and Actinobacteria (P = 0.002) and significant increases in abundances of Proteobacteria (P = 0.0002) compared to samples collected before chemotherapy. Following chemotherapy, patients had reduced capacity for nucleotide metabolism (P = 0.0001), energy metabolism (P = 0.001), metabolism of cofactors and vitamins (P = 0.006), and increased capacity for glycan metabolism (P = 0.0002), signal transduction (P = 0.0002) and xenobiotics biodegradation (P = 0.002).Conclusions: Our study identifies a severe compositional and functional imbalance in the gut microbial community associated with chemotherapy‐induced GI mucositis. The functional pathways implicated in our analysis suggest potential directions for the development of intestinal microbiome‐targeted interventions in cancer patients.

25 January 2013 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
EMEmmanuel Montassier
Emmanuel Montassier
EBE. Batard
E. Batard
TGT. Gastinne
T. Gastinne
GPG. Potel
G. Potel
MCM. F. Cochetière
M. F. Cochetière

9 November 2019 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
QBQuentin Le Bastard
Quentin Le Bastard
GCGuillaume Chapelet
Guillaume Chapelet
FJFrançois Javaudin
François Javaudin
DLDidier Lepelletier
Didier Lepelletier
EBEric Batard
Eric Batard
EMEmmanuel Montassier
Emmanuel Montassier

5 December 2017 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
QBQ. Le Bastard
Q. Le Bastard
GAG. A. Al‐Ghalith
G. A. Al‐Ghalith
MGM. Grégoire
M. Grégoire
GCG. Chapelet
G. Chapelet
FJF. Javaudin
F. Javaudin
EMEmmanuel Montassier
Emmanuel Montassier

28 April 2016 in Genome Medicine
Verified
Journal Article
Open access
PDF file
EMEmmanuel Montassier
Emmanuel Montassier
GAGabriel A. Al-Ghalith
Gabriel A. Al-Ghalith
TWTonya Ward
Tonya Ward
SCStephane Corvec
Stephane Corvec
TGThomas Gastinne
Thomas Gastinne
DKDan Knights
Dan Knights
Bacteremia, or bloodstream infection (BSI), is a leading cause of death among patients with certain types of cancer. A previous study reported that intestinal domination, defined as occupation of at least 30 % of the microbiota by a single bacterial taxon, is associated with BSI in patients undergoing allo-HSCT. However, the impact of the intestinal microbiome before treatment initiation on the risk of subsequent BSI remains unclear. Our objective was to characterize the fecal microbiome collected before treatment to identify microbes that predict the risk of BSI. We sampled 28 patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation (HSCT) prior to administration of chemotherapy and characterized 16S ribosomal RNA genes using high-throughput DNA sequencing. We quantified bacterial taxa and used techniques from machine learning to identify microbial biomarkers that predicted subsequent BSI. We found that patients who developed subsequent BSI exhibited decreased overall diversity and decreased abundance of taxa including Barnesiellaceae, Coriobacteriaceae, Faecalibacterium, Christensenella, Dehalobacterium, Desulfovibrio, and Sutterella. Using machine-learning methods, we developed a BSI risk index capable of predicting BSI incidence with a sensitivity of 90 % at a specificity of 90 % based only on the pretreatment fecal microbiome. These results suggest that the gut microbiota can identify high-risk patients before HSCT and that manipulation of the gut microbiota for prevention of BSI in high-risk patients may be a useful direction for future research. This approach may inspire the development of similar microbiome-based diagnostic and prognostic models in other diseases.

9 January 2014 in Microbial Ecology
Verified
Journal Article
Closed access
PDF file
EMEmmanuel Montassier
Emmanuel Montassier
EBEric Batard
Eric Batard
SMSébastien Massart
Sébastien Massart
TGThomas Gastinne
Thomas Gastinne
TCThomas Carton
Thomas Carton
MCMarie France de La Cochetière
Marie France de La Cochetière